Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac angiosarcoma.

Acta cardiologica·2025
Same author

Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease.

Acta cardiologica·2023
Same author

[A new approach in coronary interventional cardiology: the distal radial approach].

Revue medicale de Liege·2022
Same author

[Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy].

Revue medicale de Liege·2022
Same author

[Tricuspid regurgitation: transcatheter treatment by TriClip®].

Revue medicale de Liege·2022
Same author

[Heart failure with preserved ejection fraction (HFpEF). What's up?]

Revue medicale de Liege·2022
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Isolating and Imaging Live, Intact Pacemaker Regions of Mouse Renal Pelvis by Vibratome Sectioning
07:38

Isolating and Imaging Live, Intact Pacemaker Regions of Mouse Renal Pelvis by Vibratome Sectioning

Published on: April 30, 2021

3.8K

[Micra® leadless pacemaker].

P Lancellotti1, O Gach2, P Marechal3

  • 1Service de Cardiologie et GIGA Cardiovasculaire, CHU Liège, Belgique.

Revue Medicale De Liege
|May 10, 2019
PubMed
Summary
This summary is machine-generated.

The Micra leadless pacemaker offers a safe and effective alternative to traditional pacemakers, particularly for specific patient groups. This minimally invasive technology presents advantages like reduced infection risk and shorter procedures.

Keywords:
ComplicationsIndicationsMicraLeadless pacemaker

More Related Videos

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

10.1K
Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

3.6K

Related Experiment Videos

Last Updated: Jan 25, 2026

Isolating and Imaging Live, Intact Pacemaker Regions of Mouse Renal Pelvis by Vibratome Sectioning
07:38

Isolating and Imaging Live, Intact Pacemaker Regions of Mouse Renal Pelvis by Vibratome Sectioning

Published on: April 30, 2021

3.8K
Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
08:52

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection

Published on: February 17, 2015

10.1K
Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
09:20

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice

Published on: July 5, 2021

3.6K

Area of Science:

  • Cardiology
  • Medical Devices
  • Electrophysiology

Background:

  • Conventional transvenous pacemakers have limitations.
  • Leadless pacemakers offer a novel solution for specific patient populations.
  • Older patients with atrial fibrillation and symptomatic bradycardia may benefit from alternative pacing methods.

Purpose of the Study:

  • To compare the characteristics of the Micra leadless pacemaker with traditional transvenous pacemakers.
  • To evaluate the safety and efficacy of the Micra pacemaker.
  • To highlight the advantages of leadless pacing technology.

Main Methods:

  • Review of the Micra leadless pacemaker technology.
  • Comparison with conventional transvenous pacemaker systems.
  • Discussion of clinical implications and patient selection.

Main Results:

  • The Micra leadless pacemaker demonstrates short and mid-term safety and efficacy.
  • It serves as a viable alternative for patients lacking a conventional venous approach.
  • Advantages include a less invasive procedure, no leads, and reduced infection risk.

Conclusions:

  • The Micra leadless pacemaker is a safe and effective option for selected patients.
  • Its benefits are particularly notable for elderly patients with atrial fibrillation and bradycardia.
  • The technology offers a minimally invasive approach with comparable battery life to traditional pacemakers.